Acm Research, INC Form 4 insider transactions

Jian Wang, a key executive at ACM Research, recently exercised stock options and sold 60,000 shares of Class A Common Stock, according to a Form 4 filing with the SEC.

Mark McKechnie, CFO of ACM Research, exercised stock options and sold shares of Class A Common Stock on June 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, sold 19,239 shares of Class A Common Stock at a weighted average price of $22.63 on May 29, 2024, under a pre-arranged 10b5-1 trading plan.

David H. Wang, a director at ACM Research, sold a significant number of shares under a pre-arranged 10b5-1 trading plan.

David H. Wang, CEO of ACM Research, sold 90,000 shares of Class A Common Stock on May 22, 2024, at a weighted average price of $22.81 per share, according to a Form 4 filing with the SEC.

Haiping Dun, a director at ACM Research, Inc., sold 15,000 shares of Class A Common Stock on May 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.

ACM Research CEO David Wang exercised stock options for 180,000 shares of Class A Common Stock on May 14, 2024, resulting in a net acquisition of 176,090 shares after withholding for exercise price payment.

Haiping Dun, a director at ACM Research, exercised stock options to acquire 34,239 shares of Class A Common Stock on May 14, 2024.

ACM Research CEO David Wang sold shares of Class A Common Stock on March 14, 2024, under a pre-arranged 10b5-1 trading plan.

Director Haiping Dun of ACM Research, Inc. sold shares of Class A Common Stock on March 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Sotheara Cheav, a Senior Vice President at ACM Research, sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, sold 15,000 shares of Class A Common Stock on March 8, 2024, at a weighted average price of $30.36.

ACM Research CEO David H. Wang sold 90,000 shares of Class A Common Stock on March 8, 2024, at weighted average prices of $30.36 and $30.35, respectively, under a pre-arranged 10b5-1 trading plan.

ACM Research CEO David H. Wang exercised stock options on March 1, 2024, acquiring shares of Class A Common Stock.

Director Haiping Dun exercised stock options for 35,000 shares of ACM Research, Inc. Class A Common Stock on March 1, 2024.

Lisa Feng, CFO of ACM Research (Shanghai), exercised stock options and sold shares of Class A Common Stock on February 28, 2024.

Director Tracy Liu of ACM Research, Inc. exercised stock options and sold shares of Class A Common Stock on February 28, 2024, according to a Form 4 filing.